+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Europe Medical Foods Market Size, Share & Trends Analysis Report by Route Of Administration (Oral, Enteral), Product (Powder, Pills), Application, Module, Sales Channel, Region, and Segment Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • October 2024
  • Region: Europe
  • Grand View Research
  • ID: 6024641
The Europe medical foods market size is expected to reach USD 7.31 billion by 2030, registering a CAGR of 2.94% from 2025 to 2030. The ever-increasing burden of chronic diseases and the growing geriatric population across Europe are primary reasons for the market to flourish. In 2021, the oral route of administration accounted for the largest revenue share of 69.5%. Ease of use and high availability of medical foods in this form has contributed to the high revenue. The enteral route of administration is expected to register the fastest growth. This can be attributed to the growing geriatric population suffering from chronic diseases who are unable to consume food orally. The enteral route of administration seems to be the preferred way of administrating nutrients through medical foods to the specific needs of geriatric patients.

In the product type, the powder formulations held the largest revenue share in 2024. Owing to the vast product portfolios available in this formulation this segment has grown to a large extent. Powder formulations include nutrient mixes, protein shakes, and infant feeding formulas. The highest growth was registered by the liquid formulations due to the diversification of product portfolios of the key players in the medical foods industry. Cancer had the largest revenue share in 2024 in the applications segment. Nutritional deficiency in cancer patients is a major concern and can be managed through proper nutrient management via medical foods and is a major factor in its growth. The fastest-growing sub-segment is diabetic neuropathy, high prevalence, and has been a key driver for its fast growth.

The largest sales channel for 2024 was direct-to-consumer, owing to the emerged as a significant channel within the market, providing opportunities for manufacturers to engage directly with consumers and tailor their offerings to meet specific health needs.

Europe Medical Foods Market Report Highlights

  • Based on route of administration, the oral segment accounted for the largest revenue share of 76.1% in 2024 owing to high product type availability and ease of administration
  • In 2024, the powder formulation segment accounted for the largest revenue share of 35.2% owing to the majority product portfolio available in the market
  • By application, the cancer application segment dominated the market with the largest share of 11.7% in 2024
  • The institutional sales channel had the largest share, but the online sales channel is expected to grow at a steady rate owing to the preference of consumers and key player initiatives for sales through online channels

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
  • Competitive Landscape: Explore the market presence of key players worldwide
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

The leading players in the Europe Medical Foods market include:

  • Danone
  • Nestlé
  • Abbott
  • Targeted Medical Pharma Inc. (Physician Therapeutics LLC, a division of the company)
  • Primus Pharmaceuticals Inc.
  • Fresenius Kabi AG
  • Mead Johnson & Company, LLC


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Route of Administration
1.1.2. Product Type
1.1.3. Application
1.1.4. Module
1.1.5. Sales Channel
1.1.6. Country scope
1.1.7. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Europe Medical Foods Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Europe Medical Foods Market Analysis Tools
3.3.1. Industry Analysis - Porter’s 5 Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.3.3. COVID-19 Impact
Chapter 4. Europe Medical Foods Market: Route of Administration Estimates & Trend Analysis
4.1. Route of Administration Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Europe Medical Foods Market by Route of Administration Outlook
4.4. Oral
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Enteral
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Europe Medical Foods Market: Product Type Estimates & Trend Analysis
5.1. Product Type Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Europe Medical Foods Market by Product Type Outlook
5.4. Pills
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Powder
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Liquid
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.7. Others (semisolid, semiliquid)
5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Europe Medical Foods Market: Application Estimates & Trend Analysis
6.1. Application Market Share, 2024 & 2030
6.2. Segment Dashboard
6.3. Europe Medical Foods Market by Application Outlook
6.4. Chronic Kidney Disease
6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5. Minimal Hepatic Encephalopathy
6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.6. Chemotherapy Induced Diarrhea
6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.7. Pathogen Related Infections
6.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.8. Diabetic Neuropathy
6.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.9. ADHD
6.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.10. Depression
6.10.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.11. Alzheimer's Disease
6.11.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.12. Nutritional Deficiency
6.12.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.13. Orphan Diseases
6.13.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.14. Wound Healing
6.14.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.15. Chronic Diarrhea
6.15.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.16. Constipation Relief
6.16.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.17. Protein Booster
6.17.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.18. Dysphagia
6.18.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.19. Pain Management
6.19.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.20. Parkinson's Disease
6.20.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.21. Epilepsy
6.21.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.22. Other Cancer related treatments
6.22.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.23. Severe Protein Allergy
6.23.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.24. Cancer
6.24.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.25. Cachexia
6.25.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.26. Other (debilitating conditions, COPD, etc.)
6.26.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Europe Medical Foods Market: Modules Estimates & Trend Analysis
7.1. Modules Market Share, 2024 & 2030
7.2. Segment Dashboard
7.3. Europe Medical Foods Market by Modules Outlook
7.4. Amino Acid Module
7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.5. Protein Module
7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.6. Vitamin & Mineral Modules
7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.7. Fatty Acid based Modules
7.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.8. Carbohydrate Modules
7.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.9. Fiber Modules
7.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.10. Ketogenic Modules
7.10.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.11. Peptide based Modules
7.11.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.12. Hypoallergic Modules
7.12.1. Market estimates and forecast 2018 to 2030 (USD Million)
7.13. Others (Electrolyte Module, etc.)
7.13.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. Europe Medical Foods Market: Sales Channel Estimates & Trend Analysis
8.1. Sales Channel Market Share, 2024 & 2030
8.2. Segment Dashboard
8.3. Europe Medical Foods Market by Sales Channel Outlook
8.4. DTC Sales Channel
8.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
8.5. Institutional Sales
8.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 9. Europe Medical Foods Market: Country Estimates & Trend Analysis, By Route of Administration, By Product Type, By Application, By Module, By Sales Channel
9.1. Country Market Share Analysis, 2024 & 2030
9.2. Country Market Dashboard
9.3. Country Market Snapshot
9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.5. Europe
9.5.1. UK
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework
9.5.1.3. Competitive scenario
9.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. Germany
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework
9.5.2.3. Competitive scenario
9.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.5.3. France
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework
9.5.3.3. Competitive scenario
9.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
9.5.4. Italy
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework
9.5.4.3. Competitive scenario
9.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.5.5. Spain
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework
9.5.5.3. Competitive scenario
9.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.5.6. Norway
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework
9.5.6.3. Competitive scenario
9.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.5.7. Sweden
9.5.7.1. Key country dynamics
9.5.7.2. Regulatory framework
9.5.7.3. Competitive scenario
9.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.5.8. Denmark
9.5.8.1. Key country dynamics
9.5.8.2. Regulatory framework
9.5.8.3. Competitive scenario
9.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.5.9. Poland
9.5.9.1. Key country dynamics
9.5.9.2. Regulatory framework
9.5.9.3. Competitive scenario
9.5.9.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.5.10. Netherlands
9.5.10.1. Key country dynamics
9.5.10.2. Regulatory framework
9.5.10.3. Competitive scenario
9.5.10.4. China market estimates and forecasts 2018 to 2030 (USD Million)
9.5.11. Portugal
9.5.11.1. Key country dynamics
9.5.11.2. Regulatory framework
9.5.11.3. Competitive scenario
9.5.11.4. India market estimates and forecasts 2018 to 2030 (USD Million)
9.5.12. Slovakia
9.5.12.1. Key country dynamics
9.5.12.2. Regulatory framework
9.5.12.3. Competitive scenario
9.5.12.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.5.13. Finland
9.5.13.1. Key country dynamics
9.5.13.2. Regulatory framework
9.5.13.3. Competitive scenario
9.5.13.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.5.14. Czech Republic
9.5.14.1. Key country dynamics
9.5.14.2. Regulatory framework
9.5.14.3. Competitive scenario
9.5.14.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
9.5.15. Hungary
9.5.15.1. Key country dynamics
9.5.15.2. Regulatory framework
9.5.15.3. Competitive scenario
9.5.15.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.5.16. Belgium
9.5.16.1. Key country dynamics
9.5.16.2. Regulatory framework
9.5.16.3. Competitive scenario
9.5.16.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.3. Innovators
10.4. Vendor Landscape
10.4.1. List of key distributors and channel partners
10.4.2. Key customers
10.4.3. Key company market share analysis, 2023
10.4.4. Danone
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Technology Type benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Nestlé
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Technology Type benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Abbott
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Technology Type benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Targeted Medical Pharma Inc. (Physician Therapeutics LLC, a division of the company)
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Technology Type benchmarking
10.4.7.4. Strategic initiatives
10.4.8. Primus Pharmaceuticals Inc.
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Technology Type benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Fresenius Kabi AG
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Technology Type benchmarking
10.4.9.4. Strategic initiatives
10.4.10. Mead Johnson & Company, LLC
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Technology Type benchmarking
10.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Europe medical foods market, by region, 2018 - 2030 (USD Million)
Table 3 Europe medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 4 Europe medical foods market, by product type, 2018 - 2030 (USD Million)
Table 5 Europe medical foods market, by application, 2018 - 2030 (USD Million)
Table 6 Europe medical foods market, by modules, 2018 - 2030 (USD Million)
Table 7 Europe medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 8 Germany medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 9 Germany medical foods market, by product type, 2018 - 2030 (USD Million)
Table 10 Germany medical foods market, by application, 2018 - 2030 (USD Million)
Table 11 Germany medical foods market, by modules, 2018 - 2030 (USD Million)
Table 12 Germany medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 13 UK medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 14 UK medical foods market, by product type, 2018 - 2030 (USD Million)
Table 15 UK medical foods market, by application, 2018 - 2030 (USD Million)
Table 16 UK medical foods market, by modules, 2018 - 2030 (USD Million)
Table 17 UK medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 18 France medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 19 France medical foods market, by product type, 2018 - 2030 (USD Million)
Table 20 France medical foods market, by application, 2018 - 2030 (USD Million)
Table 21 France medical foods market, by modules, 2018 - 2030 (USD Million)
Table 22 France medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 23 Italy medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 24 Italy medical foods market, by product type, 2018 - 2030 (USD Million)
Table 25 Italy medical foods market, by application, 2018 - 2030 (USD Million)
Table 26 Italy medical foods market, by modules, 2018 - 2030 (USD Million)
Table 27 Italy medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 28 Spain medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 29 Spain medical foods market, by product type, 2018 - 2030 (USD Million)
Table 30 Spain medical foods market, by application, 2018 - 2030 (USD Million)
Table 31 Spain medical foods market, by modules, 2018 - 2030 (USD Million)
Table 32 Spain medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 33 Denmark medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 34 Denmark medical foods market, by product type, 2018 - 2030 (USD Million)
Table 35 Denmark medical foods market, by application, 2018 - 2030 (USD Million)
Table 36 Denmark medical foods market, by modules, 2018 - 2030 (USD Million)
Table 37 Denmark medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 38 Sweden medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 39 Sweden medical foods market, by product type, 2018 - 2030 (USD Million)
Table 40 Sweden medical foods market, by application, 2018 - 2030 (USD Million)
Table 41 Sweden medical foods market, by modules, 2018 - 2030 (USD Million)
Table 42 Sweden medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 43 Norway medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 44 Norway medical foods market, by product type, 2018 - 2030 (USD Million)
Table 45 Norway medical foods market, by application, 2018 - 2030 (USD Million)
Table 46 Norway medical foods market, by modules, 2018 - 2030 (USD Million)
Table 47 Norway medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 48 Poland medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 49 Poland medical foods market, by product type, 2018 - 2030 (USD Million)
Table 50 Poland medical foods market, by application, 2018 - 2030 (USD Million)
Table 51 Poland medical foods market, by modules, 2018 - 2030 (USD Million)
Table 52 Poland medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 53 Netherlands medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 54 Netherlands medical foods market, by product type, 2018 - 2030 (USD Million)
Table 55 Netherlands medical foods market, by application, 2018 - 2030 (USD Million)
Table 56 Netherlands medical foods market, by modules, 2018 - 2030 (USD Million)
Table 57 Netherlands medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 58 Portugal medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 59 Portugal medical foods market, by product type, 2018 - 2030 (USD Million)
Table 60 Portugal medical foods market, by application, 2018 - 2030 (USD Million)
Table 61 Portugal medical foods market, by modules, 2018 - 2030 (USD Million)
Table 62 Portugal medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 63 Slovakia medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 64 Slovakia medical foods market, by product type, 2018 - 2030 (USD Million)
Table 65 Slovakia medical foods market, by application, 2018 - 2030 (USD Million)
Table 66 Slovakia medical foods market, by modules, 2018 - 2030 (USD Million)
Table 67 Slovakia medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 68 Finland medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 69 Finland medical foods market, by product type, 2018 - 2030 (USD Million)
Table 70 Finland medical foods market, by application, 2018 - 2030 (USD Million)
Table 71 Finland medical foods market, by modules, 2018 - 2030 (USD Million)
Table 72 Finland medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 73 Czech Republic medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 74 Czech Republic medical foods market, by product type, 2018 - 2030 (USD Million)
Table 75 Czech Republic medical foods market, by application, 2018 - 2030 (USD Million)
Table 76 Czech Republic medical foods market, by modules, 2018 - 2030 (USD Million)
Table 77 Czech Republic medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 78 Hungary medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 79 Hungary medical foods market, by product type, 2018 - 2030 (USD Million)
Table 80 Hungary medical foods market, by application, 2018 - 2030 (USD Million)
Table 81 Hungary medical foods market, by modules, 2018 - 2030 (USD Million)
Table 82 Hungary medical foods market, by sales channel, 2018 - 2030 (USD Million)
Table 83 Belgium medical foods market, by route of administration, 2018 - 2030 (USD Million)
Table 84 Belgium medical foods market, by product type, 2018 - 2030 (USD Million)
Table 85 Belgium medical foods market, by application, 2018 - 2030 (USD Million)
Table 86 Belgium medical foods market, by modules, 2018 - 2030 (USD Million)
Table 87 Belgium medical foods market, by sales channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Europe medical foods market: market outlook
Fig. 9 Computer aided detection competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Europe medical foods market driver impact
Fig. 15 Europe medical foods market restraint impact
Fig. 16 Europe medical foods market strategic initiatives analysis
Fig. 17 Europe medical foods market: Route of administration movement analysis
Fig. 18 Europe medical foods market: Route of administration outlook and key takeaways
Fig. 19 Oral market estimates and forecast, 2018 - 2030
Fig. 20 Enteral market estimates and forecast, 2018 - 2030
Fig. 21 Europe medical foods market: Product type movement analysis
Fig. 22 Europe medical foods market: Product type outlook and key takeaways
Fig. 23 Pills market estimates and forecast, 2018 - 2030
Fig. 24 Powder market estimates and forecast, 2018 - 2030
Fig. 25 Liquid market estimates and forecast, 2018 - 2030
Fig. 26 Others (semisolid, semiliquid) market estimates and forecast, 2018 - 2030
Fig. 27 Europe medical foods market: Application model analysis
Fig. 28 Europe medical foods market: Application model outlook and key takeaways
Fig. 29 Chronic kidney disease market estimates and forecast, 2018 - 2030
Fig. 30 Minimal hepatic encephalopathy market estimates and forecast, 2018 - 2030
Fig. 31 Chemotherapy induced diarrhea market estimates and forecast, 2018 - 2030
Fig. 32 Pathogen related infections market estimates and forecast, 2018 - 2030
Fig. 33 Diabetic neuropathy market estimates and forecast, 2018 - 2030
Fig. 34 ADHD market estimates and forecast, 2018 - 2030
Fig. 35 Depression market estimates and forecast, 2018 - 2030
Fig. 36 Alzheimer's disease market estimates and forecast, 2018 - 2030
Fig. 37 Nutritional deficiency market estimates and forecast, 2018 - 2030
Fig. 38 Orphan diseases market estimates and forecast, 2018 - 2030
Fig. 39 Wound healing market estimates and forecast, 2018 - 2030
Fig. 40 Chronic diarrhea market estimates and forecast, 2018 - 2030
Fig. 41 Constipation relief market estimates and forecast, 2018 - 2030
Fig. 42 Protein booster market estimates and forecast, 2018 - 2030
Fig. 43 Dysphagia market estimates and forecast, 2018 - 2030
Fig. 44 Pain management market estimates and forecast, 2018 - 2030
Fig. 45 Parkinson's disease market estimates and forecast, 2018 - 2030
Fig. 46 Epilepsy market estimates and forecast, 2018 - 2030
Fig. 47 Other cancer related treatments market estimates and forecast, 2018 - 2030
Fig. 48 Severe protein allergy market estimates and forecast, 2018 - 2030
Fig. 49 Cancer market estimates and forecast, 2018 - 2030
Fig. 50 Cachexia market estimates and forecast, 2018 - 2030
Fig. 51 Other (debilitating conditions, COPD, etc.) market estimates and forecast, 2018 - 2030
Fig. 52 Europe medical foods market: Module model analysis
Fig. 53 Europe medical foods market: Module model outlook and key takeaways
Fig. 54 Amino acid module market estimates and forecast, 2018 - 2030
Fig. 55 Protein module market estimates and forecast, 2018 - 2030
Fig. 56 Vitamin & mineral modules market estimates and forecast, 2018 - 2030
Fig. 57 Fatty acid based modules market estimates and forecast, 2018 - 2030
Fig. 58 Carbohydrate modules market estimates and forecast, 2018 - 2030
Fig. 59 Fiber modules market estimates and forecast, 2018 - 2030
Fig. 60 Ketogenic modules market estimates and forecast, 2018 - 2030
Fig. 61 Peptide based modules market estimates and forecast, 2018 - 2030
Fig. 62 Hypoallergic modules market estimates and forecast, 2018 - 2030
Fig. 63 Others (electrolyte module, etc.) market estimates and forecast, 2018 - 2030
Fig. 64 Europe medical foods market: Country movement analysis
Fig. 65 Europe medical foods market: Country outlook and key takeaways
Fig. 66 Europe medical foods market share and leading players
Fig. 67 Europe SWOT
Fig. 68 Europe market estimates and forecasts, 2018 - 2030
Fig. 69 UK market estimates and forecasts, 2018 - 2030
Fig. 70 Germany market estimates and forecasts, 2018 - 2030
Fig. 71 France market estimates and forecasts, 2018 - 2030
Fig. 72 Italy market estimates and forecasts, 2018 - 2030
Fig. 73 Spain market estimates and forecasts, 2018 - 2030
Fig. 74 Denmark market estimates and forecasts, 2018 - 2030
Fig. 75 Sweden market estimates and forecasts, 2018 - 2030
Fig. 76 Norway market estimates and forecasts, 2018 - 2030
Fig. 77 Poland market estimates and forecasts, 2018 - 2030
Fig. 78 Netherlands market estimates and forecasts, 2018 - 2030
Fig. 79 Portugal market estimates and forecasts, 2018 - 2030
Fig. 80 Slovakia market estimates and forecasts, 2018 - 2030
Fig. 81 Finland market estimates and forecasts, 2018 - 2030
Fig. 82 Czech Republic market estimates and forecasts, 2018 - 2030
Fig. 83 Hungary market estimates and forecasts, 2018 - 2030
Fig. 84 Belgium market estimates and forecasts, 2018 - 2030
Fig. 85 Market share of key market players- Europe medical foods market

Companies Mentioned

  • Danone
  • Nestlé
  • Abbott
  • Targeted Medical Pharma Inc. (Physician Therapeutics LLC, a division of the company)
  • Primus Pharmaceuticals Inc.
  • Fresenius Kabi AG
  • Mead Johnson & Company, LLC

Methodology

Loading
LOADING...

Table Information